COMMUNIQUÉS West-GlobeNewswire

MDxHealth (R) : MDxHealth communique ses résultats financiers pour le premier semestre 2018
30/08/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES RAPPORT FINANCIER INTERMÉDIAIRE Des progrès d'exploitation satisfaisants et une croissance solide à deux chiffres des volumes de tests cliniques Conférence téléphonique [...]
IBA SA : IBA and Parkway Pantai sign contract to install proton therapy system in Singapore
30/08/2018
IBA and Parkway Pantai sign contract to install proton therapy system in Singapore First Proteus ® ONE contract in South East Asia and 24 Proteus ® ONE now sold globally Louvain-la-Neuve, Belgium, 30 August 2018 - IBA ( [...]
IBA SA : IBA et Parkway Pantai signent un contrat pour l'installation d'un système de protonthérapie à Singapour
30/08/2018
IBA et Parkway Pantai signent un contrat pour l'installation d'un système de protonthérapie à Singapour Premier contrat Proteus ® ONE en Asie du Sud-Est et 24 e Proteus ® ONE vendu dans le monde Louvain-la-Neuve, [...]
Biocartis Group NV: Biocartis announces 2018 half-year results on 6 September 2018
30/08/2018
PRESS RELEASE : REGULATED INFORMATION Thursday 30 August 2018, 07:00 CEST BIOCARTIS ANNOUNCES 2018 HALF-YEAR RESULTS ON 6 SEPTEMBER 2018 Mechelen, Belgium , 30 August 20 18 - Biocartis Group NV (the 'Company' or ' [...]
Bone Therapeutics SA announces H1 results for 2018
30/08/2018
Regulated information The interim financial report is prepared in accordance with article 13 of the Royal Decree on the obligations of issuers of financial instruments admitted to trading on a regulated market and can [...]
Bone Therapeutics SA publie ses résultats du premier semestre 2018
30/08/2018
Information réglementée Le rapport semestriel est préparé conformément au prescrit de l'article 13 de l'Arrêté Royal relatif aux obligations des émetteurs d'instruments financiers admis à la négociation sur un marché [...]
Vistin Pharma ASA : 20 per cent revenue growth in second quarter 2018
30/08/2018
Oslo, Norway, 30 August 2018 Vistin Pharma delivers a revenue growth of 20 percent from NOK 45.3 million in the second quarter 2017 to NOK 54.6 million in the second quarter 2018. The underlying demand for metformin is [...]
Probiodrug Reports Financial Results for H1 2018 and Corporate Update
30/08/2018
Probiodrug Reports Financial Results for H1 2018 and Corporate Update HALLE (SAALE), Germany, 30 August 2018 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company developing novel [...]
Kiadis Pharma announces resignation of Robbert van Heekeren and appoints Scott A. Holmes as new Chief Financial Officer
30/08/2018
Kiadis Pharma announces resignation of Robbert van Heekeren and appoints Scott A. Holmes as new Chief Financial Officer Amsterdam, The Netherlands, August 30, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company [...]
ProLynx et Daiichi Sankyo annoncent la mise au point d’une technologie permettant d’étendre la demi-vie des petites molécules dans l’œil
30/08/2018
SAN FRANCISCO, 30 août 2018 (GLOBE NEWSWIRE) -- ProLynx et Daiichi Sankyo Company, Limited ont annoncé aujourd’hui la publication d’un article dans le journal TVST intitulé « A controlled release system for long-acting [...]
MPX Bioceutical Corporation Reports Financial Results for Its Fiscal First Quarter of 2019
30/08/2018
Record Quarterly Revenues increased 224% to $14.5M TORONTO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) today reports financial results for its [...]
Assure Holdings Reports Second Quarter 2018 Financial Results
30/08/2018
– Revenue Increases by 46% to $6.0 Million, Net Income Increases to $3.3 Million – – Management to Discuss Second Quarter Results via Conference Call on Thursday, August 30, 2018, at 11:00 A.M. Eastern Time – DENVER, [...]
ContraFect to Present at Two Upcoming Investor Conferences
29/08/2018
YONKERS, N.Y., Aug. 29, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
Adverum Biotechnologies Announces IND Active for ADVM-022, a Novel Gene Therapy to Treat Wet Age-related Macular Degeneration
29/08/2018
OPTIC Phase 1 clinical trial initiation expected in 4Q18 Patients to receive a single administration of ADVM-022 delivered intravitreally 6 top U.S. retinal centers participating in the new OPTIC trial MENLO PARK, Calif [...]
MediciNova Announces the Publication of Results of the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS in the New England Journal of Medicine
29/08/2018
LA JOLLA, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
EDAP TMS SA : EDAP Reports 2018 Second Quarter Results
29/08/2018
Receives FDA clearance for novel Focal One device for prostate tissue ablation LYON, France, August 29, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global leader in therapeutic ultrasound, announced today [...]
Amedisys Partners with Medalogix to Drive Home Health Innovation
29/08/2018
Investment in Nashville Based Predictive Analytics Platform NASHVILLE, Tenn., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America's leading independent home health, hospice care and personal care [...]
Supernus to Present at September 2018 Wells Fargo Healthcare Conference
29/08/2018
ROCKVILLE, Md., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]
Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference 2018
29/08/2018
RANCHO CUCAMONGA, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President, and Bill Peters, CFO will be presenting at the Wells Fargo [...]

Pages